Literature DB >> 19349485

Prognosis and reevaluation of lung cancer by positron emission tomography imaging.

Jeremy J Erasmus1, Eric Rohren, Stephen G Swisher.   

Abstract

Positron emission tomography (PET) imaging using (18)F-2-deoxy-D-glucose, a D-glucose analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of prognosis and therapeutic response in patients with non-small cell lung cancer. FDG-PET imaging has the potential to allow more appropriate selection of patients for surgical resection and for neoadjuvant and aduvant chemotherapy as well as chemoradiation. Currently, the absence of standardization in how FDG-PET images are obtained and interpreted limits its widespread clinical utility. Although prospective multi-institutional trials and standardization of FDG-PET imaging protocols are required for the true utility to be determined, the evolving experience with FDG-PET imaging indicates a greater and integral role in treatment decisions. This article will discuss the assessment of prognosis and treatment response in patients with non-small cell lung cancer using FDG-PET, and will emphasize potential advantages and limitations in clinical management.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19349485     DOI： 10.1513/pats.200806-059LC

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


  9 in total

1.  Cancer: Clinical trials unite mice and humans.

Authors:  Leisa Johnson
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

Review 2.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

3.  Manipulations in HIWI level exerts influence on the proliferation of human non-small cell lung cancer cells.

Authors:  Yuguang Wang; Jia Liu; Guangyao Wu; Fang Yang
Journal:  Exp Ther Med       Date:  2016-02-24       Impact factor: 2.447

4.  A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.

Authors:  Zhao Chen; Katherine Cheng; Zandra Walton; Yuchuan Wang; Hiromichi Ebi; Takeshi Shimamura; Yan Liu; Tanya Tupper; Jing Ouyang; Jie Li; Peng Gao; Michele S Woo; Chunxiao Xu; Masahiko Yanagita; Abigail Altabef; Shumei Wang; Charles Lee; Yuji Nakada; Christopher G Peña; Yanping Sun; Yoko Franchetti; Catherine Yao; Amy Saur; Michael D Cameron; Mizuki Nishino; D Neil Hayes; Matthew D Wilkerson; Patrick J Roberts; Carrie B Lee; Nabeel Bardeesy; Mohit Butaney; Lucian R Chirieac; Daniel B Costa; David Jackman; Norman E Sharpless; Diego H Castrillon; George D Demetri; Pasi A Jänne; Pier Paolo Pandolfi; Lewis C Cantley; Andrew L Kung; Jeffrey A Engelman; Kwok-Kin Wong
Journal:  Nature       Date:  2012-03-18       Impact factor: 49.962

5.  Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer.

Authors:  David R Jones; Christopher A Moskaluk; Heidi H Gillenwater; Gina R Petroni; Sandra G Burks; Jennifer Philips; Patrice K Rehm; Juan Olazagasti; Benjamin D Kozower; Yongde Bao
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

6.  Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer.

Authors:  Ju Hwan Cho; Filiz Oezkan; Michael Koenig; Gregory A Otterson; James Gordon Herman; Kai He
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

Review 7.  Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.

Authors:  Feifei Na; Jingwen Wang; Cong Li; Lei Deng; Jianxin Xue; You Lu
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

8.  Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer.

Authors:  Stephen Yip; Keisha McCall; Michalis Aristophanous; Aileen B Chen; Hugo J W L Aerts; Ross Berbeco
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

9.  Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patients.

Authors:  Pierre Truntzer; Delphine N Antoni; Nicola Santelmo; Catherine Schumacher; Pierre-Emmanuel Falcoz; Elisabeth Quoix; Jean-Pierre Steib; Gilbert Massard; Georges Noël
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.